Abiopharma

New Form 424B1 - NextCure, Inc. Filed: 2025-12-11 AccNo: 0001104659-25-120346 Size: 199 KB

Director DUNTON ALAN W 🟢 acquired 4.4K shares (2 derivative) of PALATIN TECHNOLOGIES INC (PTN) at $21.38 Transaction Date: Dec 09, 2025 | Filing ID: 027267

Director PRENDERGAST JOHN K A 🟢 acquired 5.8K shares (2 derivative) of PALATIN TECHNOLOGIES INC (PTN) at $21.38 Transaction Date: Dec 09, 2025 | Filing ID: 027268

Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting

Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Director HEWSON MARILLYN A 🟢 acquired 247 shares (1 derivative) of JOHNSON & JOHNSON (JNJ) Transaction Date: Dec 09, 2025 | Filing ID: 000215

Director Pinto Daniel E 🟢 acquired 155 shares (1 derivative) of JOHNSON & JOHNSON (JNJ) Transaction Date: Dec 09, 2025 | Filing ID: 000213

(99% Neutral) AMN HEALTHCARE SERVICES, INC. (AMN) Announces Regulatory Update

Shnayder Boris 🟡 adjusted position in 5.0K shares (1 derivative) of EPAM Systems, Inc. (EPAM) at $207.00 ($1.7M) Transaction Date: Dec 10, 2025 | Filing ID: 000012

The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California

New Form 4/A - EPAM Systems, Inc. Filed: 2025-12-11 AccNo: 0001684907-25-000010 Size: 6 KB

📋 ROTHBERG JONATHAN M (Director) plans to sell 123K shares of Butterfly Network, Inc. (at $3.08 each, total $380K) Filed: Dec 11, 2025 | ID: 000086

New Form SCHEDULE 13G - Jaguar Health, Inc. Filed: 2025-12-11 AccNo: 0001462830-25-000005 Size: 10 KB

(99% Neutral) Joint Corp. (JYNT) Announces Business Combination